- Research Report University Hospital for clinical assessment GO27826Publication without faculty affiliation
- IIpilimumab in the treatment of melanoma2014 | Third Faculty of Medicine
- Early detection of colorectal cancer progression by monitoring of free tumour DNA in patient blood and plasma samplesPublication without faculty affiliation
- Léčba generalizovaného maligního melanomu kombinací inhibitoru BRAF a inhibitoru MEK - kasuistiky2016 | First Faculty of Medicine
- Adjuvant therapy for melanoma in real world2023 | Faculty of Medicine in Hradec Králové
- Serrated adenomas and carcinomas of the large intestine2014 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Trametinib2016 | First Faculty of Medicine
- Adjuvant therapy of malignant melanoma: general and practical experience2021 | Faculty of Medicine in Hradec Králové
- Safety and efficacy of vemurafenib in BRAF V600E and BRAF V600K mutatuion positive melanoma(BRIM-3): extended follow up of phase 3 randimised open label study2014 | Publication without faculty affiliation
- Dual targeted therapy in patients with malignant melanoma2017 | Faculty of Medicine in Hradec Králové
- Czech patient with lung adenocarcinoma with the BRAF V600E mutation succesfully treated with dabrafenib plus trametinib2021 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Thyroid tumors - moleculargenetic causes and choices for target therapy2012 | Central Library of Charles University
- Targeted therapy of non-small cell lung cancer2021 | Faculty of Medicine in Pilsen
- Genetics of Thyroid Cancer and its Molecular Target Therapy2011 | Central Library of Charles University
- Cetuximab in metastatic mucinous adenocarcinoma of the colon2016 | First Faculty of Medicine
- Dabrafenib in the treatment of metastatic melanoma2014 | Publication without faculty affiliation
- Malignant Melanoma - from Classical Histology towards Molecular Genetic Testing2017 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- BRAF mutation: a novel approach in targeted melanoma therapy2012 | Third Faculty of Medicine
- Modern diagnostics of Lynch syndrome2014 | Faculty of Medicine in Pilsen
- Lynch syndrome in the hands of pathologists2014 | Faculty of Medicine in Pilsen
- Molecular mechanisms of primary and secondary resistance, molecular-genetic features and characteristics of KIT/PDGFRA non-mutated GISTs2017 | Second Faculty of Medicine
- Lynch syndrome - the pathologist's diagnosis2016 | Faculty of Medicine in Pilsen